Epitalon: Telomere Research and the Pineal Connection

Epitalon: Telomere Research and the Pineal Connection — research-context featured image | Advanced Peptide Science
Key Takeaways

  • Epitalon (Epithalon, AEDG) is a synthetic tetrapeptide bioregulator with MW 390.3 Da, derived from the pineal extract Epithalamin.
  • Research investigates telomerase reverse transcriptase (hTERT) expression and telomere elongation in somatic cell preclinical models.
  • Developed by Professor Vladimir Khavinson within the broader bioregulator peptide framework — alongside Pinealon and Vilon.

What is Epitalon?

Epitalon (also called Epithalon) is a synthetic tetrapeptide bioregulator with sequence Ala-Glu-Asp-Gly (AEDG) and a molecular weight of 390.3 Da. The compound was developed by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology as the synthetic active fragment of Epithalamin — a pineal gland extract investigated for ageing-related research applications. Within the broader Khavinson bioregulator peptide framework, Epitalon is the most extensively researched member. Researchers can access Epitalon research peptide at Advanced Peptide Science within the Longevity & Immune Support category.

Research Background: The Khavinson Bioregulator Framework

The Khavinson bioregulator framework proposes that short synthetic peptides — typically 2 to 4 amino acids — regulate tissue-specific gene expression via direct DNA binding. The framework distinguishes bioregulators from classical receptor-binding pharmacology peptides by their proposed mechanism (chromatin interaction rather than receptor occupancy) and by their minimal size (small enough for hypothetical direct nuclear access). Epitalon is the tetrapeptide member of the framework; Pinealon is the tripeptide member, and Vilon is the dipeptide member — providing a structural research-tool series for investigating bioregulator size-activity relationships.

Mechanism of Action

Mechanism research investigates Epitalon-induced expression of telomerase reverse transcriptase (hTERT) — the catalytic subunit of the telomerase enzyme responsible for telomere elongation. Most somatic cells silence hTERT expression after development, leading to progressive telomere shortening across cell divisions. Pharmacological induction of hTERT expression is a research approach for investigating telomere elongation potential in somatic cell contexts. Additional Epitalon research focuses on pineal gland hormone regulation pathways — reflecting the compound’s pineal-extract origin — and broader epigenetic and chromatin-binding mechanisms hypothesised within the Khavinson framework.

Key Research Findings

Telomerase Activation

Epitalon research investigates upregulation of hTERT expression in somatic cell preclinical models. The mechanism appears to operate at the transcriptional level — increasing hTERT mRNA and protein expression rather than activating pre-existing telomerase enzyme. Downstream consequences include telomere elongation in proliferating cells, with implications for cellular replicative capacity research.

Telomere Elongation in Somatic Cells

Most somatic cell types maintain very low or zero telomerase activity. The progressive telomere shortening across cell divisions has been hypothesised to contribute to the Hayflick limit on cellular replicative capacity. Epitalon research investigates whether pharmacological hTERT induction enables telomere length maintenance or extension in somatic cell models — a research-tool framework for telomere biology investigation.

Pineal Regulation Research

The compound’s origin in pineal gland extract research supports investigation of pineal-derived signalling pathways. Research examines effects on circadian rhythm regulation, melatonin signalling, and broader neuroendocrine pineal-axis pharmacology.

Research Applications and Comparison

Epitalon is the most extensively researched Khavinson bioregulator. Comparative research with the related Pinealon (tripeptide, neuroprotection-focused) and Vilon (dipeptide, thymic-immune-focused) enables investigation of bioregulator size-activity relationships within the same proposed framework. Broader longevity-research context within the Longevity & Immune Support category includes mitochondrial-derived peptides MOTS-c and Humanin, the mitochondrial-targeted SS-31, and the senolytic FOXO4-DRI.

Research Specifications

Molecular Weight 390.3 Da
Sequence Ala-Glu-Asp-Gly (AEDG) — synthetic tetrapeptide
Origin Synthetic active fragment of pineal extract Epithalamin
Developed By Professor Vladimir Khavinson, St. Petersburg Institute of Bioregulation
Primary Mechanism Telomerase reverse transcriptase (hTERT) expression induction
Format Lyophilized powder in sterile vial
Purity ≥ 99% (HPLC verified)
Storage -20 °C, protect from light

Frequently Asked Questions

Is Epitalon the same as Epithalon?

Yes — Epitalon and Epithalon refer to the same compound. The variations reflect transliteration differences from the original Russian research literature.

What does AEDG stand for?

AEDG is the single-letter amino acid code for the tetrapeptide sequence: Ala (A) – Glu (E) – Asp (D) – Gly (G). The single-letter code is standard for short peptide sequences in research literature.

How does Epitalon relate to Pinealon and Vilon?

All three are Khavinson bioregulator peptides. Epitalon (tetrapeptide AEDG) focuses on telomerase research. Pinealon (tripeptide EDR) focuses on CNS neuroprotection. Vilon (dipeptide KE) focuses on thymic-immune research.

Is Epitalon approved for human use?

Advanced Peptide Science supplies Epitalon exclusively for in vitro and in vivo scientific research. Not for human consumption. Research use only.


For Research Use Only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.

This entry was posted in Uncategorized. Bookmark the permalink.